icometrix

icometrix

Belgium
icometrix provides clinicians with standardized measurements on their patients’ brain MRI scans in order to improve personalized care of people with a neurological disorder. icometrix was founded in 2011 by Dirk Loeckx and Wim Van Hecke. It is a spin-off company of the universities and university hospitals of Leuven and Antwerp. Today, icometrix has grown to a team of over 25 people and is internationally active, with headquarters in Leuven and an office in Boston, USA. They are the worldwide standard in MRI biomarkers in routine clinical practice. icometrix developed MSmetrix, which detects brain lesions, calculates lesion volume and measures the whole brain and grey matter volume and atrophy. MSmetrix, received market approval in the EU and other countries including Canada, Brazil and Australia. FDA clearance is pending. Furthermore, icometrix is ISO9001 and ISO13485 (Medical Devices) and ISO27001 (Information Security) certified. icometrix also acts as an image analysis expert in clinical trials and research studies. Imaging biomarkers constantly lead to new insights on neurological disorders. Since recently, imaging biomarker outcomes often serve as the primary endpoints in clinical trials for the development of new drugs. For these purposes large batches of brain imaging data are frequently transferred to icometrix for fast and high quality processing. This way our software-as-a-service is incorporated in clinical trials and large research studies regarding Traumatic Brain Injury (TBI), Epilepsy, Alzheimer’s Disease, Stroke, etc.
Founded date
01/01/2011
# of employees
11-50
Company type
For Profit

General & financials

Estimated revenue
$1M to $10M
# of funders
2
Founders
Dirk Loeckx, Wim Hecke
Industry group
Biotechnology, Health Care, Science and Engineering

Founding

Top 5 investors
Optum Ventures, Michael J. Fox Foundation, Capricorn Partners, NHS England, Forestay Capital
# of funding runds
4
Last founding
Total funded
$21.881.793

See more companies

See full list
Amethyst Radiotherapy

Amethyst Radiotherapy

Estimated revenue
$1M to $10M
# of employees
51-100
Company type
For Profit
Refocus Group

Refocus Group

Estimated revenue
$1M to $10M
# of employees
11-50
Company type
For Profit
ZyVersa Therapeutics

ZyVersa Therapeutics

Estimated revenue
$1M to $10M
# of employees
11-50
Company type
For Profit
AbilTo

AbilTo

Estimated revenue
$1M to $10M
# of employees
101-250
Company type
For Profit
Axio Biosolutions

Axio Biosolutions

Estimated revenue
$10M to $50M
# of employees
101-250
Company type
For Profit
Health Hero Network

Health Hero Network

Estimated revenue
$10M to $50M
# of employees
101-250
Company type
For Profit
Droplette

Droplette

Estimated revenue
$1M to $10M
# of employees
11-50
Company type
For Profit
REACH Health

REACH Health

Estimated revenue
$1M to $10M
# of employees
11-50
Company type
For Profit

How to get access to the full list?

Duplicate this list

Get access to a comprehensive list of companies with their industries, location and contacts infos.

Prepare outreach

Drafting good emails makes you more likely to get get results.

Track & Follow

Keeping momentum by managing all your angel investors prospects in a pipeline with pre-set stages: "contacted", "replied", "in discussion" for ex. Follow-up tightly, close in time.

What is folk?

folk is a lightweight and easy-to-use CRM that you can leverage to build lists of contacts and manage your processes with these contacts.

How to get access to this list of companies?

You can simply duplicate the list. You will need to create a folk account in order to duplicate the list properly.

What can I do with the list after duplicating it? 

On folk, you can directly email these companies and manage them in a pipeline board.